Legis Daily

Coronavirus Testing Capacity Expansion Act

USA116th CongressHR-8167| House 
| Updated: 9/4/2020
Charlie Crist

Charlie Crist

Democratic Representative

Florida

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Coronavirus Testing Capacity Expansion Act This bill requires the Department of Health and Human Services to directly reimburse laboratories for certain tests and related services during the COVID-19 (i.e., coronavirus disease 2019) emergency and expands the categories of laboratories eligible for certain COVID-19 relief funding. Specifically, veterinary and biotechnology company laboratories may receive federal COVID-19 funds for activities related to testing. Currently, this funding is limited to academic, commercial, public health, or hospital laboratories.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 4, 2020
Introduced in House
Sep 4, 2020
Referred to the House Committee on Energy and Commerce.
  • September 4, 2020
    Introduced in House


  • September 4, 2020
    Referred to the House Committee on Energy and Commerce.

Health

AppropriationsCardiovascular and respiratory healthDepartment of Health and Human ServicesEmergency medical services and trauma careEmployee hiringExecutive agency funding and structureGeneticsHealth personnelHealth programs administration and fundingHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsVeterinary medicine and animal diseases

Coronavirus Testing Capacity Expansion Act

USA116th CongressHR-8167| House 
| Updated: 9/4/2020
Coronavirus Testing Capacity Expansion Act This bill requires the Department of Health and Human Services to directly reimburse laboratories for certain tests and related services during the COVID-19 (i.e., coronavirus disease 2019) emergency and expands the categories of laboratories eligible for certain COVID-19 relief funding. Specifically, veterinary and biotechnology company laboratories may receive federal COVID-19 funds for activities related to testing. Currently, this funding is limited to academic, commercial, public health, or hospital laboratories.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 4, 2020
Introduced in House
Sep 4, 2020
Referred to the House Committee on Energy and Commerce.
  • September 4, 2020
    Introduced in House


  • September 4, 2020
    Referred to the House Committee on Energy and Commerce.
Charlie Crist

Charlie Crist

Democratic Representative

Florida

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AppropriationsCardiovascular and respiratory healthDepartment of Health and Human ServicesEmergency medical services and trauma careEmployee hiringExecutive agency funding and structureGeneticsHealth personnelHealth programs administration and fundingHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsVeterinary medicine and animal diseases